To Investigate the Incidence of Reflux in Patients After Per-oral Endoscopic Myotomy in Achalasia Cardia Patients
1 other identifier
observational
64
1 country
1
Brief Summary
Achalasia is a rare motility disorder of the oesophagus that is characterized by aperistalsis of the oesophagal body and dysrelaxation of the lower oesophagal sphincter (LES). Current treatment is palliative, and the aim of the treatment is to diminish the obstructive function of the esophagogastric junction (EGJ). Due to this approach, the most frequent complication post-treatment is gastroesophageal reflux (GER). However, not every treated patient develops GER symptoms and the mechanism behind the occurrence of GER in treated achalasia are unclear. In this study, we aim to Investigate the incidence of reflux in patients after peroral endoscopic myotomy in patients with achalasia cardia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 1, 2021
CompletedStudy Start
First participant enrolled
July 1, 2021
CompletedFirst Posted
Study publicly available on registry
July 7, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2022
CompletedJanuary 31, 2023
January 1, 2023
6 months
June 1, 2021
January 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To Investigate the incidence of reflux in patients after peroral endoscopic myotomy in achalasia cardia patients.
To study the incidence of true reflux in patients with achalasia cardia who have undergone peroral endoscopic myotomy with 24 hour ambulatory pH monitoring.
Three months
Study Arms (1)
Achalasia cardia patients - post peroral endoscopic myotomy
All the patients who will undergo peroral endoscopic myotomy for the treatment of achalasia cardia patients.
Interventions
Peroral endoscopic myotomy involves an initial incision on the internal lining of the oesophagus. This permits entry of the endoscope to within the wall of the oesophagus, where the muscle will be exposed. The inner layer of the muscle near the lower oesophagal sphincter will be cut (this is termed myotomy). At the conclusion of the procedure, the oesophagal incision will be closed with standard endoscopic clips.
Eligibility Criteria
Treated achalasia patients with and without gastroesophageal reflux symptoms visiting the outpatient clinic of the Gastroenterology Department.
You may qualify if:
- A- Treated achalasia patients with gastroesophageal reflux symptoms
- Diagnosis of idiopathic achalasia confirmed by oesophageal manometry that shows the following criteria:
- Aperistalsis or simultaneous contractions in the oesophageal body.
- Impaired relaxation of the Lower oesophageal sphincter
- Treatment of achalasia with per-oral endoscopic myotomy (POEM)
- The minimum total score on the Gastroesophageal Reflux Disease Questionnaire (GERDQ) of ≥ 8.
- Gastroesophageal symptoms after treatment lasting more than three months.
- Age 18-80 years.
- Written informed consent.
- B- Treated achalasia patients without gastroesophageal reflux symptoms
- Diagnosis of idiopathic achalasia confirmed by oesophagal manometry that shows the following criteria:
- Aperistalsis or simultaneous contractions in the oesophageal body.
- Impaired relaxation of the Lower oesophageal sphincter
- Treatment of achalasia with per-oral endoscopic myotomy (POEM)
- The maximum total score on the Gastroesophageal Reflux Disease Questionnaire (GERDQ) of \< 8.
- +2 more criteria
You may not qualify if:
- Pseudoachalasia.
- Upper gastrointestinal malignancy.
- Chagas disease.
- Peptic ulcer disease.
- Inability to stop PPI, H2-receptor antagonist or prokinetic drug for two weeks
- Presence of an extremely dilated oesophagus body \>5 cm
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AIG Hospitals
Hyderabad, Telangana, 500032, India
Related Publications (18)
Boeckxstaens GE. The lower oesophageal sphincter. Neurogastroenterol Motil. 2005 Jun;17 Suppl 1:13-21. doi: 10.1111/j.1365-2982.2005.00661.x.
PMID: 15836451RESULTCampos GM, Vittinghoff E, Rabl C, Takata M, Gadenstatter M, Lin F, Ciovica R. Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis. Ann Surg. 2009 Jan;249(1):45-57. doi: 10.1097/SLA.0b013e31818e43ab.
PMID: 19106675RESULTLopushinsky SR, Urbach DR. Pneumatic dilatation and surgical myotomy for achalasia. JAMA. 2006 Nov 8;296(18):2227-33. doi: 10.1001/jama.296.18.2227.
PMID: 17090769RESULTAnderson SH, Yadegarfar G, Arastu MH, Anggiansah R, Anggiansah A. The relationship between gastro-oesophageal reflux symptoms and achalasia. Eur J Gastroenterol Hepatol. 2006 Apr;18(4):369-74. doi: 10.1097/00042737-200604000-00009.
PMID: 16538107RESULTCrookes PF, Corkill S, DeMeester TR. Gastroesophageal reflux in achalasia. When is reflux really reflux? Dig Dis Sci. 1997 Jul;42(7):1354-61. doi: 10.1023/a:1018873501205.
PMID: 9246028RESULTvan Herwaarden MA, Samsom M, Smout AJ. Prolonged manometric recordings of oesophagus and lower oesophageal sphincter in achalasia patients. Gut. 2001 Dec;49(6):813-21. doi: 10.1136/gut.49.6.813.
PMID: 11709516RESULTShoenut JP, Micflikier AB, Yaffe CS, Den Boer B, Teskey JM. Reflux in untreated achalasia patients. J Clin Gastroenterol. 1995 Jan;20(1):6-11. doi: 10.1097/00004836-199501000-00004.
PMID: 7884182RESULTKatzka DA, Sidhu M, Castell DO. Hypertensive lower esophageal sphincter pressures and gastroesophageal reflux: an apparent paradox that is not unusual. Am J Gastroenterol. 1995 Feb;90(2):280-4.
PMID: 7847301RESULTNovais PA, Lemme EM. 24-h pH monitoring patterns and clinical response after achalasia treatment with pneumatic dilation or laparoscopic Heller myotomy. Aliment Pharmacol Ther. 2010 Nov;32(10):1257-65. doi: 10.1111/j.1365-2036.2010.04461.x. Epub 2010 Sep 25.
PMID: 20955445RESULTShoenut JP, Duerksen D, Yaffe CS. A prospective assessment of gastroesophageal reflux before and after treatment of achalasia patients: pneumatic dilation versus transthoracic limited myotomy. Am J Gastroenterol. 1997 Jul;92(7):1109-12.
PMID: 9219779RESULTSpechler SJ, Souza RF, Rosenberg SJ, Ruben RA, Goyal RK. Heartburn in patients with achalasia. Gut. 1995 Sep;37(3):305-8. doi: 10.1136/gut.37.3.305.
PMID: 7590421RESULTEckardt VF, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology. 1992 Dec;103(6):1732-8. doi: 10.1016/0016-5085(92)91428-7.
PMID: 1451966RESULTRohof WO, Hirsch DP, Kessing BF, Boeckxstaens GE. Efficacy of treatment for patients with achalasia depends on the distensibility of the esophagogastric junction. Gastroenterology. 2012 Aug;143(2):328-35. doi: 10.1053/j.gastro.2012.04.048. Epub 2012 May 2.
PMID: 22562023RESULTRohof WO, Lei A, Boeckxstaens GE. Esophageal stasis on a timed barium esophagogram predicts recurrent symptoms in patients with long-standing achalasia. Am J Gastroenterol. 2013 Jan;108(1):49-55. doi: 10.1038/ajg.2012.318. Epub 2012 Sep 25.
PMID: 23007004RESULTVaezi MF, Baker ME, Achkar E, Richter JE. Timed barium oesophagram: better predictor of long term success after pneumatic dilation in achalasia than symptom assessment. Gut. 2002 Jun;50(6):765-70. doi: 10.1136/gut.50.6.765.
PMID: 12010876RESULTKwiatek MA, Kahrilas K, Soper NJ, Bulsiewicz WJ, McMahon BP, Gregersen H, Pandolfino JE. Esophagogastric junction distensibility after fundoplication assessed with a novel functional luminal imaging probe. J Gastrointest Surg. 2010 Feb;14(2):268-76. doi: 10.1007/s11605-009-1086-1.
PMID: 19911238RESULTHemmink GJ, Bredenoord AJ, Weusten BL, Timmer R, Smout AJ. Does acute psychological stress increase perception of oesophageal acid? Neurogastroenterol Motil. 2009 Oct;21(10):1055-e86. doi: 10.1111/j.1365-2982.2009.01327.x. Epub 2009 May 15.
PMID: 19453516RESULTSingh AP, Singla N, Budhwani E, Januszewicz W, Memon SF, Inavolu P, Nabi Z, Jagtap N, Kalapala R, Lakhtakia S, Darisetty S, Reddy DN, Ramchandani M. Defining "true acid reflux" after peroral endoscopic myotomy for achalasia: a prospective cohort study. Gastrointest Endosc. 2024 Feb;99(2):166-173.e3. doi: 10.1016/j.gie.2023.08.008. Epub 2023 Aug 19.
PMID: 37598862DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aniruddha P Singh, MBBS,MD,DM
AIG hospitals,India
- STUDY DIRECTOR
Mohan Ramchandani, MBBS,MD,DM
AIG Hospitals,India
- STUDY CHAIR
Nageshwar Reddy, MBBS,MD,DM
AIG Hospitals,India
- PRINCIPAL INVESTIGATOR
Pradev Inavolu, MBBS, MD, DM
AIG Hospitals, India
- PRINCIPAL INVESTIGATOR
Hardik Rughwani, MBBS, MD, DM
AIG Hospitals, India
- PRINCIPAL INVESTIGATOR
Neeraj Singla, MBBS, MD, DM
AIG Hospitals, India
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 1, 2021
First Posted
July 7, 2021
Study Start
July 1, 2021
Primary Completion
December 15, 2021
Study Completion
March 15, 2022
Last Updated
January 31, 2023
Record last verified: 2023-01